瑞芬太尼
參考資料

↑  . www.ultiva.com.   [2015-11-30]. （原始内容存档于2019-04-20）.
↑  Gesztesi Z, Mootz BL, White PF. The use of a remifentanil infusion for hemodynamic control during intracranial surgery. Anesth Analg. 1999;89(5):1282-1287
↑  Grottke O, Dietrich PJ, Wiegels S, Wappler F. Intraoperative wake-up test and postoperative emergence in patients undergoing spinal surgery: a comparison of intravenous and inhaled anesthetic techniques using short-acting anesthetics. Anesth Analg. 2004;99(5):1521-1527.
↑  De Baerdemaeker LEC, Jacobs S, Pattyn P, Mortier EP, Struys MMRF. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. Br J Anaesth. 2007;99(3):404-411.
↑  De Baerdemaeker LEC, Jacobs S, Pattyn P, Mortier EP, Struys MMRF. Influence of intraoperative opioid on postoperative pain and pulmonary function after laparoscopic gastric banding: remifentanil TCI vs sufentanil TCI in morbid obesity. Br J Anaesth. 2007;99(3):404-411.
↑  Michelsen LG, Hug CC Jr. The pharmacokinetics of remifentanil. J Clin Anesth 1996;8:679–82
↑  Guy J, Hindman BJ, Baker KZ, et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology. 1997;86(3):514-524.
↑  Weale NK, Rogers CA, Cooper R, Nolan J, Wolf AR. . Br J Anaesth. February 2004, 92 (2): 187–94. PMID 14722167. doi:10.1093/bja/aeh038 .
↑  .   [21 Aug 2014]. （原始内容存档于2014-08-21） （瑞典语）.
↑  White, L. D.; Hodsdon, A.; An, G. H.; Thang, C.; Melhuish, T. M.; Vlok, R. . International Journal of Obstetric Anesthesia. 1 November 2019, 40: 4–13  [2023-04-03]. ISSN 0959-289X. PMID 31230994. doi:10.1016/j.ijoa.2019.04.007 . hdl:10072/416502. （原始内容存档于2021-08-28） （英语）.
↑  Stocki, Daniel; Matot, Idit; Einav, Sharon; Eventov-Friedman, Smadar; Ginosar, Yehuda; Weiniger, Carolyn F. . Anesthesia and Analgesia. Mar 2014, 118 (3): 589–97. PMID 24149580. S2CID 4844447. doi:10.1213/ANE.0b013e3182a7cd1b .
↑  Ulusoy H H. . J Int Med Res. Feb 2014, 42 (1): 111–119. PMID 24398757. doi:10.1177/0300060513509036 .
↑  Bodor, Nicholas; Buchwald, Peter. . Medicinal Research Reviews. 2000, 20 (1): 58–101. PMID 10608921. S2CID 25119421. doi:10.1002/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X.
↑  Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. . J. Pharmacol. Exp. Ther. April 1997, 281 (1): 226–32. PMID 9103501.
1 2  Patel SS, Spencer CM. . Drugs. Sep 1996, 52 (3): 417–27. PMID 8875131. doi:10.2165/00003495-199652030-00009.
↑  Dahaba, Ashraf A.; Grabner, Tanja; Rehak, Peter H.; List, Werner F.; Metzler, Helfried. . Anesthesiology. 2004-09-01, 101 (3): 640–646  [2023-04-03]. ISSN 0003-3022. PMID 15329588. S2CID 17192694. doi:10.1097/00000542-200409000-00012. （原始内容存档于2021-05-25） （英语）.
↑  Spies, Claudia; MacGuill, Martin; Heymann, Anja; Ganea, Christina; Krahne, Daniel; Assman, Angelika; Kosiek, Heinrich-Rudolf; Scholtz, Kathrin; Wernecke, Klaus-Dieter; Martin, Jörg. . Intensive Care Medicine. March 2011, 37 (3): 469–476. ISSN 0342-4642. PMID 21165734. doi:10.1007/s00134-010-2100-5  （英语）.
↑  Ternes, J. W., & O'Brien, C. P. (1990). The opioids: Abuse liability and treatments for dependence. Advances in alcohol & substance abuse, 9(1-2), 27-45.
↑  Panlilio, L. V., & Schindler, C. W. (2000). Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats. Psychopharmacology, 150(1), 61-66.
↑  Baylon, G. J., Kaplan, H. L., Somer, G., Busto, U. E., & Sellers, E. M. (2000). Comparative abuse liability of intravenously administered remifentanil and fentanyl. Journal of clinical psychopharmacology, 20(6), 597-606.
↑  Levine, A. I., & Bryson, E. O. (2010). Intranasal self-administration of remifentanil as the foray into opioid abuse by an anesthesia resident. Anesthesia & Analgesia, 110(2), 524-525.
↑  Feldman, P. L. (2006). Discovery and Development of the Ultrashort-acting Analgesic Remifentanil. Drug Discovery and Development, Drug Discovery, 1, 339.
↑  Gatlin, Larry Alan, Shirley Ann Heiman, and Janet Sue Lewis. "Stable formulations of remifentanil." U.S. Patent No. 5,866,591. 2 Feb. 1999.
↑  US Food and Drug Administration. (2010). Orange book: approved drug products with therapeutic equivalence evaluations. Silver Spring, MD: US FDA.